🇺🇸 FDA
Pipeline program

SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, CARBOPLATIN

D20181321

Phase 2 small_molecule active

Quick answer

SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, CARBOPLATIN for recurrent primary supratentorial malignant brain tumors in children is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
recurrent primary supratentorial malignant brain tumors in children
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials